Table IV.
Canonical pathways | P-value | Molecules |
---|---|---|
Virus entry via endocytic pathways | 0.0002 | B2M, CAV1, TFRC |
Allograft rejection signaling | 0.0019 | B2M, IL2 |
OX40 signaling pathway | 0.0025 | B2M, IL2 |
Caveolar-mediated endocytosis signaling | 0.0044 | B2M, CAV1 |
Communication between innate and adaptive immune cells | 0.0056 | B2M, IL2 |
Chronic myeloid leukemia signaling | 0.0071 | CTBP1, E2F4 |
Molecular mechanisms of cancer | 0.0102 | DAXX, CDH1, E2F4 |
DNA double-strand break repair by homologous recombination | 0.0191 | ATRX |
Lipid antigen presentation by CD1 | 0.0257 | B2M |
Antiproliferative role of TOB in T cell signaling | 0.0355 | IL2 |
Colorectal cancer metastasis signaling | 0.0407 | CDH1, E2F4 |
Role of CHK proteins in cell cycle checkpoint control | 0.0447 | E2F4 |
Cell cycle regulation by BTG family proteins | 0.0468 | E2F4 |